共 50 条
- [42] Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment [J]. CRITICAL CARE, 2018, 22
- [49] Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis [J]. MEDICAL SCIENCE MONITOR, 2012, 18 (05): : HY13 - HY17
- [50] Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials [J]. Critical Care, 28 (1):